The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels

被引：0
|
作者：
Jean-Philippe Drouin-Chartier
Jean-Charles Hogue
André J. Tremblay
Jean Bergeron
Benoît Lamarche
Patrick Couture
机构：
[1] Institute of Nutrition and Functional Foods (INAF),
[2] Lipid Research Centre,undefined
[3] CHU de Québec-Université Laval,undefined
来源：
Lipids in Health and Disease | / 16卷
关键词：
Familial hypercholesterolemia; Apolipoprotein B-48; PCSK9; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 44 条
  • [21] Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profile
    Lupo, Maria Giovanna
    Arcidiacono, Diletta
    Zaramella, Alice
    Fimiani, Fabio
    Calabro, Paolo
    Cefalu, Angelo Baldassare
    Averna, Maurizio
    D'Erasmo, Laura
    Arca, Marcello
    De Martin, Sara
    Zambon, Alberto
    Ferri, Nicola
    ATHEROSCLEROSIS PLUS, 2021, 43 : 7 - 9
  • [22] PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
    Rogacev, Kyrill S.
    Heine, Gunnar H.
    Silbernagel, Guenther
    Kleber, Marcus E.
    Seiler, Sarah
    Emrich, Insa
    Lennartz, Simone
    Werner, Christian
    Zawada, Adam M.
    Fliser, Danilo
    Boehm, Michael
    Maerz, Winfried
    Scharnagl, Hubert
    Laufs, Ulrich
    PLOS ONE, 2016, 11 (01):
  • [23] TREATMENT WITH PCSK9 INHIBITORS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA LOWERS PLASMA LEVELS OF PLATELET ACTIVATING FACTOR AND ITS PRECURSORS: A COMBINED METABOLOMIC AND LIPIDOMIC APPROACH
    Di Minno, A.
    Calcaterra, I. L.
    Orsini, R.
    Chiesa, M.
    Cavalca, V.
    Anesi, A.
    Fiorelli, S.
    Eligini, S.
    Colombo, G.
    Donnarumma, S.
    Palermo, V.
    Tremoli, E.
    Porro, B.
    Di Minno, M. N. D.
    ATHEROSCLEROSIS, 2023, 379 : S63 - S64
  • [24] Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High-Dose Statin Therapy
    Raal, Frederick
    Panz, Vanessa
    Immelman, Andrew
    Pilcher, Gillian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02):
  • [25] Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies
    Almontashiri, Naif A. M.
    Vilmundarson, Ragnar O.
    Ghasemzadeh, Nima
    Dandona, Sonny
    Roberts, Robert
    Quyyumi, Arshed A.
    Chen, Hsiao-Huei
    Stewart, Alexandre F. R.
    PLOS ONE, 2014, 9 (09):
  • [26] Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach
    Di Minno, Alessandro
    Orsini, Roberta Clara
    Chiesa, Mattia
    Cavalca, Viviana
    Calcaterra, Ilenia
    Tripaldella, Maria
    Anesi, Andrea
    Fiorelli, Susanna
    Eligini, Sonia
    Colombo, Gualtiero, I
    Tremoli, Elena
    Porro, Benedetta
    Di Minno, Matteo Nicola Dario
    BIOMEDICINES, 2021, 9 (08)
  • [27] ANALYSIS OF THE LDLR, APOB, PCSK9 AND LDLRAP1 GENES VARIABILITY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN WEST SIBERIA USING TARGETED HIGH THROUGHPUT RESEQUENCING
    Shakhtshneider, E.
    Ivanoshchuk, D.
    Orlov, P.
    Timoshchenko, O.
    Voevoda, M.
    ATHEROSCLEROSIS, 2019, 287 : E285 - E285
  • [28] Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study
    Toru Miyoshi
    Keigo Nakamura
    Masayuki Doi
    Hiroshi Ito
    American Journal of Cardiovascular Drugs, 2015, 15 : 213 - 219
  • [29] Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study
    Miyoshi, Toru
    Nakamura, Keigo
    Doi, Masayuki
    Ito, Hiroshi
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (03) : 213 - 219
  • [30] PCSK9 INHIBITORS ALTER THE DISTRIBUTION OF MACROPHAGEDERIVED CHOLESTEROL EFFLUX TO FAMILIAL HYPERCHOLESTEROLEMIA LIPOPROTEINS AND PROMOTE MACROPHAGE-SPECIFIC REVERSE CHOLESTEROL TRANSPORT IN VIVO
    Borras, C.
    Canyelles, M.
    Girona, J.
    Plana, N.
    Revilla, G.
    Llorente-Cortes, V.
    Kovanen, P. T.
    Jauhiainen, M.
    Lee-Rueckert, M.
    Arrieta, F.
    Martinez-Botas, J.
    Gomez-Coronado, D.
    Ribalta, J.
    Blanco-Vaca, F.
    Tondo, M.
    Escola-Gil, J. C.
    ATHEROSCLEROSIS, 2023, 379 : S62 - S62
12345